v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue, net $ 10,785 $ 10,698
Costs and operating expenses:    
Cost of product revenue 1,329 1,262
Research and development 66,213 42,857
Selling and marketing 16,577 14,148
General and administrative 20,006 16,348
Total costs and operating expenses 104,125 74,615
Loss from operations (93,340) (63,917)
Other income (expense):    
Interest income 6,050 3,826
Interest expense (2,777) (2,984)
Change in fair value of derivative liabilities 1,455 (978)
Total other income (expense), net 4,728 (136)
Net loss $ (88,612) $ (64,053)
Net loss per share, basic (in dollars per share) $ (0.4) $ (0.38)
Weighted average common shares outstanding, basic (in shares) 224,099,410 169,396,989
Net loss per share, diluted (in dollars per share) $ (0.4) $ (0.38)
Weighted average common shares outstanding, diluted (in shares) 224,099,410 169,396,989
Product revenue, net    
Revenue:    
Total revenue, net $ 10,785 $ 10,634
Collaboration revenue    
Revenue:    
Total revenue, net   $ 64